LT2575802T - Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui - Google Patents
Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymuiInfo
- Publication number
- LT2575802T LT2575802T LTEP11726567.8T LT11726567T LT2575802T LT 2575802 T LT2575802 T LT 2575802T LT 11726567 T LT11726567 T LT 11726567T LT 2575802 T LT2575802 T LT 2575802T
- Authority
- LT
- Lithuania
- Prior art keywords
- phosphaplatins
- cancers
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35151410P | 2010-06-04 | 2010-06-04 | |
| PCT/US2011/038948 WO2011153365A1 (en) | 2010-06-04 | 2011-06-02 | Phosphaplatins and their use for treatment of cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2575802T true LT2575802T (lt) | 2016-12-27 |
Family
ID=44627266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP11726567.8T LT2575802T (lt) | 2010-06-04 | 2011-06-02 | Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US9688709B2 (lt) |
| EP (1) | EP2575802B1 (lt) |
| JP (1) | JP5860872B2 (lt) |
| KR (1) | KR101775410B1 (lt) |
| CN (6) | CN108409795B (lt) |
| AP (1) | AP3480A (lt) |
| AU (1) | AU2011261381B2 (lt) |
| BR (1) | BR112012030927B1 (lt) |
| CA (1) | CA2800898C (lt) |
| CL (1) | CL2012003416A1 (lt) |
| CO (1) | CO6640302A2 (lt) |
| CY (1) | CY1118466T1 (lt) |
| DK (1) | DK2575802T3 (lt) |
| EA (1) | EA021526B1 (lt) |
| ES (1) | ES2606855T3 (lt) |
| HR (1) | HRP20170225T1 (lt) |
| HU (1) | HUE030249T2 (lt) |
| IL (1) | IL223405B (lt) |
| LT (1) | LT2575802T (lt) |
| MX (1) | MX2012014174A (lt) |
| MY (1) | MY162902A (lt) |
| NZ (1) | NZ603952A (lt) |
| PH (1) | PH12012502394A1 (lt) |
| PL (1) | PL2575802T3 (lt) |
| PT (1) | PT2575802T (lt) |
| RS (1) | RS55714B1 (lt) |
| SG (1) | SG185722A1 (lt) |
| SI (1) | SI2575802T1 (lt) |
| SM (2) | SMT201700056T1 (lt) |
| WO (1) | WO2011153365A1 (lt) |
| ZA (1) | ZA201209007B (lt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2575802T (lt) | 2010-06-04 | 2016-12-27 | Ohio University | Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui |
| EP2663301A1 (en) * | 2011-01-12 | 2013-11-20 | Ohio University | Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
| CN104010508B (zh) * | 2011-10-05 | 2017-03-15 | 理辛德拉·N·博斯 | 用于大规模制备磷铂类抗肿瘤剂的高效方法 |
| MX357865B (es) * | 2011-10-05 | 2018-07-25 | N Bose Rathindra | Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos. |
| CN104540839B (zh) * | 2012-05-24 | 2017-02-22 | 弗斯普拉廷治疗有限责任公司 | 磷铂化合物的合成和提纯方法及其用途 |
| US9333211B2 (en) * | 2013-02-22 | 2016-05-10 | University Of Houston System | Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof |
| WO2015127037A1 (en) * | 2014-02-19 | 2015-08-27 | University Of Houston System | Compositions and methods for the treatment of neurodegenerative diseases |
| SG11201808717QA (en) * | 2016-04-06 | 2018-11-29 | Phosplatin Therapeutics Llc | Phosphaplatin liquid formulations |
| KR102718532B1 (ko) * | 2017-01-06 | 2024-10-21 | 프로몬토리 테라퓨틱스 인코포레이티드 | 뼈 또는 혈액 암의 치료를 위한 치료제로서의 포스파플라틴 화합물 |
| CA3074020A1 (en) * | 2017-09-08 | 2019-03-14 | Phosplatin Therapeutics Llc | Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof |
| CA3196140A1 (en) * | 2020-10-20 | 2022-04-28 | Tyler D. Ames | Phosphaplatin compounds as therapeutic agents selectively targeting highly glycolytic tumor cells and methods thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4234500A (en) | 1979-03-07 | 1980-11-18 | Engelhard Minerals & Chemicals Corporation | Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes |
| US4291027A (en) | 1979-03-07 | 1981-09-22 | Engelhard Minerals & Chemicals Corp. | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes |
| CA2017739A1 (en) | 1989-07-18 | 1991-01-18 | Leslie S. Hollis | Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
| AUPR330201A0 (en) | 2001-02-23 | 2001-03-22 | University Of Sydney, The | Metal complexes and therapeutic uses thereof |
| DE10314780A1 (de) | 2003-03-19 | 2004-09-30 | Ktb Tumorforschungsgesellschaft Mbh | Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden |
| US20070160656A1 (en) | 2003-05-02 | 2007-07-12 | Dziewiszek Krzysztof J | Lipid platinum complexes and methods of use thereof |
| WO2005000858A2 (en) | 2003-06-27 | 2005-01-06 | Akira Odani | Bisphosphonate complexes |
| WO2009008345A1 (ja) | 2007-07-06 | 2009-01-15 | Tmrc Co., Ltd. | 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 |
| PL2173337T3 (pl) * | 2007-08-06 | 2014-11-28 | Univ Ohio | Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę |
| WO2011125911A1 (ja) | 2010-03-31 | 2011-10-13 | 国立大学法人金沢大学 | 金属錯体およびこれを有効成分として含有する抗がん剤 |
| LT2575802T (lt) | 2010-06-04 | 2016-12-27 | Ohio University | Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui |
| EP2663301A1 (en) | 2011-01-12 | 2013-11-20 | Ohio University | Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
| MX357865B (es) * | 2011-10-05 | 2018-07-25 | N Bose Rathindra | Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos. |
-
2011
- 2011-06-02 LT LTEP11726567.8T patent/LT2575802T/lt unknown
- 2011-06-02 WO PCT/US2011/038948 patent/WO2011153365A1/en not_active Ceased
- 2011-06-02 SI SI201131103A patent/SI2575802T1/sl unknown
- 2011-06-02 EP EP11726567.8A patent/EP2575802B1/en active Active
- 2011-06-02 AP AP2012006594A patent/AP3480A/xx active
- 2011-06-02 EA EA201270812A patent/EA021526B1/ru unknown
- 2011-06-02 SM SM20170056T patent/SMT201700056T1/it unknown
- 2011-06-02 ES ES11726567.8T patent/ES2606855T3/es active Active
- 2011-06-02 PL PL11726567T patent/PL2575802T3/pl unknown
- 2011-06-02 SG SG2012086229A patent/SG185722A1/en unknown
- 2011-06-02 CN CN201810150496.9A patent/CN108409795B/zh active Active
- 2011-06-02 CN CN201810150470.4A patent/CN108392490A/zh active Pending
- 2011-06-02 JP JP2013513350A patent/JP5860872B2/ja active Active
- 2011-06-02 CN CN201810150487.XA patent/CN108210516A/zh active Pending
- 2011-06-02 HU HUE11726567A patent/HUE030249T2/en unknown
- 2011-06-02 CN CN201810150614.6A patent/CN108299508A/zh not_active Withdrawn
- 2011-06-02 RS RS20170139A patent/RS55714B1/sr unknown
- 2011-06-02 PT PT117265678T patent/PT2575802T/pt unknown
- 2011-06-02 AU AU2011261381A patent/AU2011261381B2/en active Active
- 2011-06-02 MY MYPI2012005178A patent/MY162902A/en unknown
- 2011-06-02 NZ NZ603952A patent/NZ603952A/en unknown
- 2011-06-02 CN CN2011800387165A patent/CN103037859A/zh active Pending
- 2011-06-02 MX MX2012014174A patent/MX2012014174A/es active IP Right Grant
- 2011-06-02 DK DK11726567.8T patent/DK2575802T3/en active
- 2011-06-02 PH PH1/2012/502394A patent/PH12012502394A1/en unknown
- 2011-06-02 CN CN201810150598.0A patent/CN108186651A/zh active Pending
- 2011-06-02 KR KR1020137000158A patent/KR101775410B1/ko active Active
- 2011-06-02 HR HRP20170225TT patent/HRP20170225T1/hr unknown
- 2011-06-02 CA CA2800898A patent/CA2800898C/en active Active
- 2011-06-02 BR BR112012030927-7A patent/BR112012030927B1/pt active IP Right Grant
- 2011-06-02 US US13/701,313 patent/US9688709B2/en active Active
-
2012
- 2012-11-28 ZA ZA2012/09007A patent/ZA201209007B/en unknown
- 2012-12-03 IL IL223405A patent/IL223405B/en active IP Right Grant
- 2012-12-04 CO CO12219958A patent/CO6640302A2/es not_active Application Discontinuation
- 2012-12-04 CL CL2012003416A patent/CL2012003416A1/es unknown
-
2016
- 2016-12-22 CY CY20161101332T patent/CY1118466T1/el unknown
-
2017
- 2017-01-25 SM SM201700056T patent/SMT201700056B/it unknown
- 2017-05-24 US US15/604,237 patent/US10364264B2/en active Active
- 2017-05-24 US US15/604,209 patent/US10385083B2/en active Active
-
2019
- 2019-06-26 US US16/453,303 patent/US10759820B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276362A (en) | Cancer treatment methods | |
| IL248530A0 (en) | Biomarkers and treatment methods | |
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| SG10201508495VA (en) | Combination treatment of cancer | |
| AP3480A (en) | Phosphaplatins and their use for treatment of cancers | |
| EP2539005A4 (en) | ORAL PIECE AND METHODS OF USING THE SAME | |
| IL222227A0 (en) | Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use | |
| EP2603202A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES | |
| IL223189A0 (en) | Methods of treatment of pancreatic cancer | |
| HRP20171352T1 (hr) | Wnt-antagonisti i postupci liječenja | |
| ZA201300218B (en) | Treatment of blood cancer | |
| EP2574172A4 (en) | MATERIALS AND METHOD FOR TREATING INFLAMMATION | |
| ZA201304225B (en) | Methods of treating cancer | |
| IL256026B (en) | Treatment methods | |
| EP2640390A4 (en) | METHODS OF TREATING CANCER | |
| GB201011411D0 (en) | Therapeutic compounds and their use | |
| GB201412831D0 (en) | Detection and treatment of breast cancer | |
| EP2709730A4 (en) | TREATMENT AND PROGNOSIS OF CANCER | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| GB201017354D0 (en) | Treatment of cancer | |
| GB201017356D0 (en) | Combination treatment of cancer | |
| GB201002499D0 (en) | Treatment of tumours | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer | |
| ZA201301175B (en) | Biomarkers and methods of treatment | |
| GB201009194D0 (en) | Treatment of pain |